HHS drops Solomon exclusion, and critics focus on Forest's revenue forecasts
This article was originally published in Scrip
Executive Summary
The US Department of Health and Human Services has decided it will not seek to exclude Forest Laboratories' chairman, CEO and president, Howard Solomon, from doing business with government medical reimbursement programmes after all. The HHS's Office of the Inspector General (HHS-OIG) has written to the company saying it has closed the case and anticipates no further action in relation to the matter in question.